Recombinant gene effectors and compositions and methods of use thereof

JP2025510781APending Publication Date: 2025-04-15EPICRISPR BIOTECHNOLOGIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024556421
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-13
Filing Date
2023-03-23
Publication Date
2025-04-15

Smart Images

  • Figure 2025510781000001_ABST
    Figure 2025510781000001_ABST
Patent Text Reader

Abstract

The present disclosure provides one or more recombinant gene effectors, as well as systems, compositions and methods of use thereof, wherein the one or more recombinant gene effectors of the present disclosure can be used to regulate a target gene in a cell (e.g., an endogenous target gene in a cell).The one or more recombinant gene effectors of the present disclosure can be operably linked to a heterologous endonuclease, such as a CRISPR / Cas protein.
Need to check novelty before this filing date? Find Prior Art